After decades of unfulfilled promises and setbacks, the field of gene therapy broke through with three FDA-approved products last year, ushering in what is likely to be a rapid escalation of new treatments for some of the rarest and most debilitating diseases.
“Part of the idea of the Human Genome project was that once we had the identity of all the genes, it would be important and straight forward for us to development more therapeutic options for people with serious inherited diseases, said Katherine High, M.D., president and director of research and development for Philadelphia-based Spark Therapeutics. “But it turned out this took a little longer to do than the Human Genome project.” Continue reading
Some may find it funny. Others struggle to discuss it. Still others shrug it off as a “normal” part of aging. No matter how you may look at it, bladder control issues are no joke for millions of older people in the U.S. Incontinence and over-active bladder (OAB) can wreak havoc on a person’s life.
It can lead to depression, social isolation or serious side effects from certain medications that treat the condition. Continue reading
A nursing home demonstration project in Indiana has reduced avoidable hospitalizations among residents by a third, according to a recently released independent evaluation of OPTIMISTIC, (Optimizing Patient Transfers, Impacting Medical quality and Improving Symptoms: Transforming Institutional Care).
OPTIMISTIC is a Centers for Medicare and Medicaid (CMS) demonstration program designed to improve chronic disease management and boost staff education and training.
The proposed combination of one of the nation’s largest health insurers, Cigna Corp., and the nation’s largest pharmacy benefits manager (PBM), Express Scripts Holdings Company, is unlikely to benefit consumers much, if at all. But to their credit, health care journalists are digging into how consumers might benefit from the deal.
These questions are important, given that the Cigna-Express Scripts deal follows an announcement three months earlier that CVS Health would pay $69 billion for Aetna Inc., another major health insurers, in a deal “that could reshape the health industry,” as the New York Times reported. Pharmacy retailer CVS Health also owns a PBM, CVS/Caremark. Continue reading
Last year, there were 115 hospital and health system mergers and acquisitions – the highest number recorded in recent history, according to a report from Kaufman, Hall & Associates, a management consulting company that tracks M&A deals in health care.
The number and size of these transactions are transforming the health care system, the company said: “The implications reach far beyond the unprecedented number of individual transactions. Organizational size and scale have mattered for decades – but today, they are proving to be imperatives.” Continue reading